UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
Marten Transport
MRTN
$1.05B
| $1.02M | ﹤0.01% |
95,701
-76,272
| -44% | -$927K |
2018 Q2
29 quarters
|
|
2002
Ethan Allen Interiors
ETD
$513M
| $1.02M | ﹤0.01% |
34,611
-81,892
| -70% | -$2.42M |
2013 Q2
49 quarters
|
|
2003
AnaptysBio
ANAB
$1.46B
| $1.02M | ﹤0.01% |
33,271
-16,534
| -33% | -$379K |
2023 Q1
10 quarters
|
|
2004
Stagwell
STGW
$2.23B
| $1.01M | ﹤0.01% |
180,128
-157,034
| -47% | -$833K |
2021 Q4
15 quarters
|
|
2005
Accendra Health
ACH
$20.1M
| $1.01M | ﹤0.01% |
211,119
-108,471
| -34% | -$690K |
2013 Q2
49 quarters
|
|
2006
JOYY Inc
JOYY
$4.07B
| $1M | ﹤0.01% |
17,133
+9,933
| +138% | +$546K |
2015 Q4
39 quarters
|
|
2007
First Watch Restaurant Group
FWRG
$763M
| $1M | ﹤0.01% |
64,007
-358,637
| -85% | -$6.25M |
2023 Q4
7 quarters
|
|
2008
Forward Air
FWRD
$535M
| $1M | ﹤0.01% |
39,026
-23,212
| -37% | -$668K |
2013 Q2
49 quarters
|
|
2009
Forestar Group
FOR
$1.31B
| $1,000K | ﹤0.01% |
37,590
-18,757
| -33% | -$481K |
2023 Q1
10 quarters
|
|
2010
Ventas
VTR
$43.5B
| $998K | ﹤0.01% |
14,256
-5,605,833
| -100% | -$377M |
2013 Q2
49 quarters
|
|
2011
BlueLinx
BXC
$576M
| $996K | ﹤0.01% |
13,634
-11,811
| -46% | -$931K |
2022 Q2
13 quarters
|
|
2012
Republic Bancorp
RBCAA
$1.8B
| $995K | ﹤0.01% |
13,769
-9,422
| -41% | -$696K |
2022 Q4
11 quarters
|
|
2013
HealthStream
HSTM
$1.03B
| $986K | ﹤0.01% |
34,918
-40,433
| -54% | -$1.11M |
2018 Q1
30 quarters
|
|
2014
Chemours
CC
$1.94B
| $984K | ﹤0.01% |
62,114
+7,509
| +14% | +$109K |
2015 Q3
40 quarters
|
|
2015
CNA Financial
CNA
$12.8B
| $984K | ﹤0.01% |
21,173
+1,234
| +6% | +$57.2K |
2017 Q1
34 quarters
|
|
2016
DELISTED
Integral Ad Science
IAS
| $983K | ﹤0.01% |
96,703
-98,876
| -51% | -$856K |
2023 Q3
8 quarters
|
|
2017
Kura Oncology
KURA
$863M
| $980K | ﹤0.01% |
110,766
-78,954
| -42% | -$563K |
2019 Q3
24 quarters
|
|
2018
Axogen
AXGN
$2.09B
| $980K | ﹤0.01% |
54,945
-57,436
| -51% | -$833K |
2025 Q1
2 quarters
|
|
2019
GigaCloud Technology
GCT
$2.12B
| $978K | ﹤0.01% |
34,447
-36,055
| -51% | -$940K |
2024 Q3
4 quarters
|
|
2020
Arhaus
ARHS
$1.44B
| $971K | ﹤0.01% |
91,354
-55,544
| -38% | -$585K |
2024 Q2
5 quarters
|
|
2021
Ichor Holdings
ICHR
$1.75B
| $969K | ﹤0.01% |
55,331
-46,127
| -45% | -$876K |
2019 Q3
24 quarters
|
|
2022
Chiron Real Estate Inc
XRN
$415M
| $964K | ﹤0.01% |
28,609
+21,295
| +291% | +$758K |
2019 Q4
23 quarters
|
|
2023
Greif Class B
GEF.B
$4.18B
| $962K | ﹤0.01% |
15,613
-9,917
| -39% | -$667K |
2022 Q4
11 quarters
|
|
2024
Sinclair Inc
SBGI
$918M
| $960K | ﹤0.01% |
63,583
-45,109
| -42% | -$647K |
2013 Q2
49 quarters
|
|
2025
Liberty Latin America Class A
LILA
$1.62B
| $960K | ﹤0.01% |
170,452
-73,848
| -30% | -$369K |
2018 Q3
28 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.